Literature DB >> 25354204

Tetraspanin CD63 acts as a pro-metastatic factor via β-catenin stabilization.

Bastian Seubert1, Haissi Cui, Nicole Simonavicius, Katja Honert, Sandra Schäfer, Ute Reuning, Mathias Heikenwalder, Bernard Mari, Achim Krüger.   

Abstract

The tetraspanin CD63 is implicated in pro-metastatic signaling pathways but, so far, it is unclear, how CD63 levels affect the tumor cell phenotype. Here, we investigated the effect of CD63 modulation in different metastatic tumor cell lines. In vitro, knock down of CD63 induced a more epithelial-like phenotype concomitant with increased E-cadherin expression, downregulation of its repressors Slug and Zeb1, and decreased N-cadherin. In addition, β-catenin protein was markedly reduced, negatively affecting expression of the target genes MMP-2 and PAI-1. β-catenin inhibitors mimicked the epithelial phenotype induced by CD63 knock down. Inhibition of β-catenin upstream regulators PI3K/AKT or GSK3β could rescue the mesenchymal phenotype underlining the importance of the β-catenin pathway in CD63-regulated cell plasticity. CD63 knock down-induced phenotypical changes correlated with a decrease of experimental metastasis whereas CD63 overexpression enhanced the tumor cell-intrinsic metastatic potential. Taken together, our data show that CD63 is a crucial player in the regulation of the tumor cell-intrinsic metastatic potential by affecting cell plasticity.
© 2014 UICC.

Entities:  

Keywords:  CD63; E-cadherin; GSK3; PI3K; beta-catenin; cancer; epithelial mesenchymal transition (EMT); mesenchymal to epithelial transition (MET); metastasis; tetraspanin

Mesh:

Substances:

Year:  2014        PMID: 25354204     DOI: 10.1002/ijc.29296

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  15 in total

1.  Tetraspanin CD63 independently predicts poor prognosis in colorectal cancer.

Authors:  Tuomas Kaprio; Jaana Hagström; Leif C Andersson; Caj Haglund
Journal:  Histol Histopathol       Date:  2020-02-19       Impact factor: 2.303

2.  Tspan8-β-catenin positive feedback loop promotes melanoma invasion.

Authors:  Manale El Kharbili; Gweltaz Agaësse; Laetitia Barbollat-Boutrand; Roxane M Pommier; Arnaud de la Fouchardière; Lionel Larue; Julie Caramel; Alain Puisieux; Odile Berthier-Vergnes; Ingrid Masse
Journal:  Oncogene       Date:  2019-01-24       Impact factor: 9.867

3.  From Autonomy to Integration, From Integration to Dynamically Balanced Integrated Co-existence: Non-aging as the Third Stage of Development.

Authors:  Lev Salnikov; Mamuka G Baramiya
Journal:  Front Aging       Date:  2021-03-25

4.  CD63 acts as a functional marker in maintaining hematopoietic stem cell quiescence through supporting TGFβ signaling in mice.

Authors:  Mengjia Hu; Yukai Lu; Song Wang; Zihao Zhang; Yan Qi; Naicheng Chen; Mingqiang Shen; Fang Chen; Mo Chen; Lijing Yang; Shilei Chen; Dongfeng Zeng; Fengchao Wang; Yongping Su; Yang Xu; Junping Wang
Journal:  Cell Death Differ       Date:  2021-08-06       Impact factor: 15.828

5.  Exosome-mediated transfer of miR-222 is sufficient to increase tumor malignancy in melanoma.

Authors:  Federica Felicetti; Alessandra De Feo; Carolina Coscia; Rossella Puglisi; Francesca Pedini; Luca Pasquini; Maria Bellenghi; Maria Cristina Errico; Elena Pagani; Alessandra Carè
Journal:  J Transl Med       Date:  2016-02-24       Impact factor: 5.531

6.  Decreased expression of CD63 tetraspanin protein predicts elevated malignant potential in human esophageal cancer.

Authors:  Xiaojing Lai; Qing Gu; Xia Zhou; Wei Feng; Xiao Lin; Yan He; Jinming Cao; Pengfei Liu; Huojun Zhang; Xiao Zheng
Journal:  Oncol Lett       Date:  2017-04-11       Impact factor: 2.967

Review 7.  Tetraspanins Function as Regulators of Cellular Signaling.

Authors:  Christina M Termini; Jennifer M Gillette
Journal:  Front Cell Dev Biol       Date:  2017-04-06

8.  Myoferlin is a novel exosomal protein and functional regulator of cancer-derived exosomes.

Authors:  Arnaud Blomme; Karim Fahmy; Olivier Peulen; Brunella Costanza; Marie Fontaine; Ingrid Struman; Dominique Baiwir; Edwin de Pauw; Marc Thiry; Akeila Bellahcène; Vincent Castronovo; Andrei Turtoi
Journal:  Oncotarget       Date:  2016-12-13

9.  The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling.

Authors:  Dorian Forte; Valentina Salvestrini; Giulia Corradi; Lara Rossi; Lucia Catani; Roberto M Lemoli; Michele Cavo; Antonio Curti
Journal:  Oncotarget       Date:  2017-01-10

Review 10.  Prognostic Value of CD63 Expression in Solid Tumors: A Meta-analysis of the Literature.

Authors:  Hyun Min Koh; Bo Gun Jang; Dong Chul Kim
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.